Author: admin

  • Finalised Inland Revenue guidance on share cancellations: a further chapter in the “dividend integrity” journey | Tax Alert – October 2025

    Finalised Inland Revenue guidance on share cancellations: a further chapter in the “dividend integrity” journey | Tax Alert – October 2025

    By Campbell Rose, Greg Mitchell & Anna Roche

     

    In September 2025 Inland Revenue published Interpretation Statement 25/19 Whether an off-market share cancellation is made in lieu of the payment of a dividend (IS 25/19), which finalised the draft interpretation statement (IS) issued for public consultation earlier this year and replaces previous guidance from 1999.

    As we discussed in our May 2025 Tax Alert article the draft IS was, generally, welcome updated guidance on whether a share cancellation is in lieu of a dividend. However, it was not without some potential fish-hooks, which were raised with officials as part of the consultation process. We summarise below how some of those submissions fared.

    Submission areas

    Some suggestions raised in submissions included that:

    • The IS should establish clearer boundaries as to where Inland Revenue considers there is a risk that the redemption of non-participating redeemable shares (NPRS) is in lieu of a dividend;
    • Where part of an amount is treated as in lieu of a dividend, tainting the entire amount paid could capture legitimate returns of available subscribed capital (ASC); equally, the IS should clarify that an actual dividend portion of an overall payout upon share cancellation should not taint the entire amount;
    • The scope of the IS should be refined in relation to non-pro-rata buy-backs, including acknowledging the commercial drivers for such buy-backs, appropriately recognising what is an “unusual event”, clarifying the implications of contemporaneously issuing shares to other shareholders, and addressing the position of investment companies; and
    • An example in the draft IS (example 4) should be clarified so that the inability of a company to pay a dividend (e.g., due to annual losses since incorporation) should be a factor that indicates a redemption is not in lieu of a dividend – rather than being only a “neutral” factor as described in the draft IS.
    Updates in the final published IS 25/19

    The finalised IS 25/19 included the usual minor ‘tidy ups’ and clarifications that arise through the consultation process, as well as some notable changes, including:

    • A new example (example 10) that illustrates a scenario when a redemption of NPRS would not be considered in lieu of a dividend. Although example 10 supports the starting point that a redemption of NPRS should only be in lieu of a dividend in extreme cases, in our view more value could have been derived from an example clarifying the limited circumstances in which a redemption of NPRS would be in lieu of a dividend. In particular, IS 25/19 does not reference relevant extrinsic material (published by Inland Revenue in August 1994) confirming that, illustratively, the “in lieu of dividend” test should be triggered in an NPRS context where a company ceases a regular dividend flow to shareholders and ensures those shareholders receive an equivalent amount by redeeming NPRS. The example does, however, demonstrate that a commercial reason for cancelling shares is to facilitate a shareholder exit. It also clarifies that it is not only the first ever share cancellation or redemption that may be considered a “one-off” unusual transaction.
    • An additional example supports that issuing shares after a cancellation does not necessarily indicate that the cancellation is in lieu of a dividend; as the cancellation and reissue can have a legitimate commercial rationale without any suggestion that the reissue is to circumvent the bright-line tests.
    • Clarifying that a cancellation payment comprising both ASC (capable of being returned tax-free) and an additional (excess) dividend component is not, without a purpose of avoidance, intended to be captured by the ‘tainting’ which can occur when part of such a payment is “in lieu of” a dividend.
    • Updates have been made to what was example 4 (now 5), to confirm that a company with no retained earnings and ongoing tax losses is not in a dividend-paying position, and therefore the cancellation in the example should not be in lieu of a dividend. This is sensible, as it re-confirms that a company needs to be in a dividend paying position for a share cancellation to be considered in lieu of a dividend.

    Areas not updated in IS 25/19

    Inland Revenue did not address all of the key concerns that were raised in submissions.

    IS 29/15 does not acknowledge that non pro-rata buy-backs generally should not be considered to be in lieu of a dividend (other than in rare circumstances). This point is of fundamental importance to investment companies, as their business model is often to redeem or cancel the shares of some shareholders while contemporaneously issuing new equity to other shareholders. A clear statement providing guidance in this context would have been a welcome addition to provide certainty; instead it appears that the tax implications will need to be firmly grounded in the commercial drivers specific to the business model and particular redemption(s)/re-issuance(s).

    Inland Revenue did not consider there was scope to apply a purposive approach to interpreting the “all or nothing” nature of the tainting language in the in lieu of dividend rule, based on the legislation as drafted and its intended scope. This issue has been referred to policy officials for further consideration.

    Where to from here?

    “Dividend avoidance/integrity” is currently, and we expect will continue to be, a key focus area for Inland Revenue. It represents an area of avoidance-related investigation where Inland Revenue’s enquiries can be assumed to commence from a sceptical starting point – and potentially in scenarios where the statutory time bar may not apply.

    Accordingly, in defending a share cancellation as being genuine, it will be critical to retain objective evidence that compellingly supports the commercial reasons underpinning the cancellation. This needs to then be appropriately weighted with the other statutory factors in section CD 22(7) of the Income Tax Act 2007 to support a position that none of the amount paid is in lieu of a dividend.

    As IS 25/19 has been updated to include reference to “inexplicable accumulation of earnings”, “examin[ing] the source of (…) funds” for “objective evidence that they represent genuine surplus capital and not simply accumulated profits”. In the context of examples the analysis also uses new terminology of dividends being “effectively deferred”, and “utilis[ing] a bank account of accumulated profits”.

    It is therefore imperative that companies tread carefully in this area, given heightened Inland Revenue scrutiny of the capital/revenue (dividend) boundary. As we noted in our May 2025 article, obtaining appropriate specialist tax advice and achieving valuable certainty through a binding ruling before undertaking a share cancellation, warrant serious consideration.

    If you have any questions on IS 25/19 or the tax implications more generally of share cancellations, please contact your usual Deloitte advisor.

    Continue Reading

  • Vicente Luque Has Found Peace

    Vicente Luque Has Found Peace

    Neal won the fight via knockout, the first man to stop the Brazilian via strikes, and Luque was diagnosed with a subdural hematoma — a bleed on the brain — that instantly put his career in jeopardy. Luque was medically suspended for a year…

    Continue Reading

  • APA Corporation Provides Third-Quarter 2025 Supplemental Information and Schedules Results Conference Call for Nov. 6 at 10 a.m. Central Time – APA Corporation

    1. APA Corporation Provides Third-Quarter 2025 Supplemental Information and Schedules Results Conference Call for Nov. 6 at 10 a.m. Central Time  APA Corporation
    2. APA Corp (APA) Reports Q2 2025: Improved Permian Efficiency and Steady Dividend Payouts  Yahoo Finance
    3. APA Corporation Provides Third-Quarter 2025 Supplemental  GlobeNewswire
    4. Are APA’s (APA) Rig Reductions a Sign of Efficiency or a Shift in Growth Priorities?  simplywall.st
    5. Analysts Cite Return-of-Capital and Egyptian Gas Growth as Catalysts for APA (APA)  Insider Monkey

    Continue Reading

  • William Kentridge opera to have its New York premiere at Powerhouse Arts in Brooklyn – The Art Newspaper

    William Kentridge opera to have its New York premiere at Powerhouse Arts in Brooklyn – The Art Newspaper

    William Kentridge’s award-winning chamber opera Waiting for the Sibyl (2019) makes its New York premiere this week in Brooklyn (until 11 October). The debut comes as part of the inaugural Powerhouse: International arts festival at Powerhouse…

    Continue Reading

  • Building the future of healthcare in LATAM

    Building the future of healthcare in LATAM

    Latin America’s (LATAM) healthcare landscape is vibrant and complex. It’s woven from diverse populations, economic shifts, and a powerful drive for innovation. The region’s health systems are navigating a period of profound transformation, demanding smarter, more connected solutions.

    Transformational trends shaping healthcare in the region

    Across Latin America, several powerful trends are reshaping the delivery of care. Three forces in particular stand out as critical drivers of change.

    1. Telehealth 2.0: from pandemic response to integrated care

    The adoption of telehealth across Latin America has been remarkable. What began as a necessary response to the pandemic is now evolving into a permanent and integrated part of the healthcare ecosystem. The telehealth market in the region is projected to exceed US $22 billion by 2030, signalling a permanent shift in how patients and providers interact.

    This move toward “Telehealth 2.0” creates hybrid workflows that blend virtual and in-person services. Brazil is at the forefront, with a strong legal framework supporting telemedicine and e-prescriptions. However, rapid growth presents a challenge: how do we ensure the quality and consistency of care when it’s delivered virtually, across countless individual encounters? Preventing errors across settings is a top priority for health leaders.

    2. Workforce disequilibrium: the clinician shortage and burnout crisis

    It is no secret that Latin America faces a significant shortage of healthcare workers. The World Health Organization projects a 10 million worker shortfall globally by 2030, a gap that is felt acutely in our region. In countries like Brazil, Argentina, and Colombia, the nurse-to-physician ratio is well below the OECD average, placing great strain on existing staff.

    This disequilibrium is not just about numbers; it’s about skill distribution and burnout. Experienced specialists are often concentrated in urban centers, leaving primary care and rural facilities to rely on less experienced staff. For clinicians everywhere, the cognitive load is immense, leading to high rates of burnout and staff turnover—a costly problem for any health system.

    3. Chronic diseases and antimicrobial resistance

    Like many regions, Latin America is grappling with a rising tide of non-communicable diseases (NCDs). Chronic conditions like diabetes and hypertension now represent a major challenge, accounting for a significant portion of healthcare expenditure. And antimicrobial resistance (AMR) has become a critical public health threat, with resistance rates for certain bacteria climbing to alarming levels in countries like Brazil.

    This dual pressure is forcing hospital leaders to find new ways to manage resources effectively. With budgets under strain, there is a clear need for data-driven stewardship. The challenge is to optimize treatment and control costs without compromising patient outcomes, a goal that requires deep insight into clinical practice patterns.

    Introducing UpToDate Enterprise Edition

    We’re delighted to officially launch UpToDate® Enterprise Edition in Latin America to help address these challenges. UpToDate Enterprise Edition is more than an information resource; it’s a strategic tool designed to help healthcare organizations navigate these complex trends. It empowers both clinical and non-clinical users with the evidence and insights needed to build a more efficient, effective, and sustainable health system.

    1. AI-enhanced search for faster, more confident decisions

    For clinicians working in fast-paced environments getting to the right answer quickly is critical. UpToDate Enterprise Edition features a powerful, AI-enhanced search that understands natural language. A doctor can ask a multi-faceted question and receive a precise, evidence-based answer in seconds.

    This capability helps standardize care quality across all settings by giving every clinician access to the same trusted expertise. By reducing the time spent searching for information, it also helps to lessen the cognitive burden on our clinical workforce, improving confidence and reducing the risk of burnout.

    2. Advanced analytics for data-driven leadership

    While clinicians need answers, hospital executives need data to make strategic decisions. The analytics portal in UpToDate Enterprise Edition provides leaders with a system-wide view of clinical activity. You can identify trends in drug and condition searches, spot knowledge gaps among staff, and benchmark your organization’s patterns against others.

    For example, a hospital director can use the portal to see which antibiotics are most frequently researched, providing data to support an antimicrobial stewardship program. Or identify areas where junior staff are seeking guidance most often, allowing for targeted training and mentorship. These insights turn clinical usage data into actionable intelligence for improving operational efficiency, managing costs, and supporting quality and compliance initiatives.

    3. A trusted partner in a new era of healthcare

    For over 30 years, UpToDate has been a trusted partner to the global medical community. UpToDate Enterprise Edition extends this legacy with tools designed for the interconnected nature of modern healthcare, including our new generative AI functionality UpToDate Expert AI. Organizations with Enterprise Edition can test our GenAI interface through our AI Labs (limited to 5 users and non-point of care use).

    With UpToDate Enterprise Edition, health systems gain a partner that helps them deliver better care today while building a sustainable and data-driven foundation for the future.

    See UpToDate Enterprise Edition in action

    UpToDate Enterprise Edition offers capabilities that address our region’s most pressing challenges. It’s a solution designed to connect care teams, optimize operations, and elevate the quality of care across the diverse environments that define Latin America.

    If you’d like to see how UpToDate Enterprise Edition can support your organization, we invite you to contact us to schedule a demo.

    Continue Reading

  • From handshakes to hard lines — and no laddoos – Tribune India

    From handshakes to hard lines — and no laddoos – Tribune India

    1. From handshakes to hard lines — and no laddoos  Tribune India
    2. Mohsin Naqvi told he isn’t ‘big enough to decide’ whether Asia Cup should be awarded or not: ‘Trophy will come to India’  Hindustan Times
    3. Cricket in the age of Nationalistic Machismo  

    Continue Reading

  • Disney raises admission prices for its theme parks during key holidays – Reuters

    1. Disney raises admission prices for its theme parks during key holidays  Reuters
    2. Disneyland and Disney World Increasing Prices for Tickets, Annual Passes, Lightning Lane, and More  Mickey Visit
    3. Disney increases ticket, annual pass prices. How to…

    Continue Reading

  • Macron will nominate new French prime minister in 48 hours

    Macron will nominate new French prime minister in 48 hours

    French President Emmanuel Macron will name a new prime minister within 48 hours, the Elysee Palace has said, fending off speculation that fresh elections could be imminent.

    Earlier on Wednesday, outgoing Prime Minister Sébastien Lecornu said the…

    Continue Reading

  • Data: Pediatric hospital strain amid 2022-23 respiratory virus season not tied to decline in beds

    Data: Pediatric hospital strain amid 2022-23 respiratory virus season not tied to decline in beds

    A Yale University–led research team reports that high US pediatric hospital bed occupancy (bed strain) and large differences in between-hospital bed occupancy (load imbalance) were common during the 2022-23 respiratory virus season, but weren’t…

    Continue Reading

  • Rhodes Announces The Custom Keys Challenge: A Global Scoring Competition with a Rhodes MK8 Grand Prize

    Rhodes Announces The Custom Keys Challenge: A Global Scoring Competition with a Rhodes MK8 Grand Prize

    Leeds, United Kingdom, October 7, 2025 — Rhodes Music today announces The Custom Keys Challenge, a competition open to music creators worldwide to score a new Rhodes short film using Rhodes sounds as the foundation. The winner will…

    Continue Reading